A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
News: December, 2019
A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy.
According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.
W. Kimryn Rathmell, MD, PhD, has been named as interim chair of the Department of Medicine in the Vanderbilt University School of Medicine. Her appointment is effective Jan. 1, 2020.
Vanderbilt-Ingram Cancer Center’s Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.
John Wilson, PhD, assistant professor of Chemical and Biomolecular Engineering at Vanderbilt University, received a $50,000 research grant at the 2019 Vanderbilt-Ingram Cancer Center Ambassador Breakfast.